(Q43671252)

25 November 2017

title

Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause? (English)

1 reference

25 November 2017

0 references

9

Elisabetta Bugianesi

1 reference

25 November 2017

11

Tania Roskams

1 reference

25 November 2017

author name string

David van der Poorten

1

1 reference

25 November 2017

Caroline F Samer

2

1 reference

25 November 2017

Mehdi Ramezani-Moghadam

3

1 reference

25 November 2017

Sally Coulter

4

1 reference

25 November 2017

Marina Kacevska

5

1 reference

25 November 2017

Dennis Schrijnders

6

1 reference

25 November 2017

Lindsay E Wu

7

1 reference

25 November 2017

Duncan McLeod

8

1 reference

25 November 2017

Mina Komuta

10

1 reference

25 November 2017

Christopher Liddle

12

1 reference

25 November 2017

Lionel Hebbard

13

1 reference

25 November 2017

Jacob George

14

1 reference

25 November 2017

language of work or name

English

0 references

publication date

18 January 2013

1 reference

25 November 2017

1 reference

25 November 2017

volume

57

1 reference

25 November 2017

issue

6

1 reference

25 November 2017

page(s)

2180-2188

1 reference

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

25 November 2017

cites work

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis

21 January 2018

1 reference

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

21 January 2018

1 reference

The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease

21 January 2018

1 reference

Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

21 January 2018

1 reference

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

21 January 2018

1 reference

Pioglitazone in the treatment of NASH: the role of adiponectin

21 January 2018

1 reference

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

21 January 2018

1 reference

Study of adiponectin in chronic liver disease and cholestasis

21 January 2018

1 reference

Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics

21 January 2018

1 reference

Nonalcoholic steatohepatitis: definition and pathology

21 January 2018

1 reference

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model

21 January 2018

1 reference

Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression

21 January 2018

1 reference

The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo

21 January 2018

1 reference

A G protein-coupled receptor responsive to bile acids

21 January 2018

1 reference

Significance of serum adiponectin levels in patients with chronic liver disease

21 January 2018

1 reference

Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism

21 January 2018

1 reference

Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B.

21 January 2018

1 reference

The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology

21 January 2018

1 reference

Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis

21 January 2018

1 reference

Role of bile acids and bile acid receptors in metabolic regulation

21 January 2018

1 reference

The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice

21 January 2018

1 reference

Focal sparing of segment IV in fatty livers shown by sonography and CT: correlation with aberrant gastric venous drainage

21 January 2018

1 reference

Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease

21 January 2018

1 reference

Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial

21 January 2018

1 reference

Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation

21 January 2018

1 reference

7 January 2021

Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow

1 reference

7 January 2021

Effect of cirrhosis on energy expenditure

1 reference

7 January 2021

High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo

1 reference

7 January 2021

Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease

1 reference

7 January 2021

Two cases from the spectrum of nonalcoholic steatohepatitis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26072

1 reference

25 November 2017

1 reference